Article info

Download PDFPDF
Mast cells in early rheumatoid arthritis associate with disease severity and support B cell autoantibody production

Authors

  • Felice Rivellese Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK PubMed articlesGoogle scholar articles
  • Daniele Mauro Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK PubMed articlesGoogle scholar articles
  • Alessandra Nerviani Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK PubMed articlesGoogle scholar articles
  • Sara Pagani Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK PubMed articlesGoogle scholar articles
  • Liliane Fossati-Jimack Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK PubMed articlesGoogle scholar articles
  • Tobias Messemaker Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands PubMed articlesGoogle scholar articles
  • Fina A S Kurreeman Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands PubMed articlesGoogle scholar articles
  • René E M Toes Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands PubMed articlesGoogle scholar articles
  • Andreas Ramming Department of Internal Medicine 3–Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Germany PubMed articlesGoogle scholar articles
  • Simon Rauber Department of Internal Medicine 3–Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Germany PubMed articlesGoogle scholar articles
  • Georg Schett Department of Internal Medicine 3–Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Germany PubMed articlesGoogle scholar articles
  • Gareth W Jones Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, UK PubMed articlesGoogle scholar articles
  • Simon A Jones Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, UK PubMed articlesGoogle scholar articles
  • Francesca Wanda Rossi Department of Translational Medical Sciences and Center for Basic and Clinical Immunology Research (CISI), World Allergy Organization (WAO) Center of Excellence, University of Naples Federico II, Naples, Italy PubMed articlesGoogle scholar articles
  • Amato de Paulis Department of Translational Medical Sciences and Center for Basic and Clinical Immunology Research (CISI), World Allergy Organization (WAO) Center of Excellence, University of Naples Federico II, Naples, Italy PubMed articlesGoogle scholar articles
  • Gianni Marone Department of Translational Medical Sciences and Center for Basic and Clinical Immunology Research (CISI), World Allergy Organization (WAO) Center of Excellence, University of Naples Federico II, Naples, Italy Institute of Experimental Endocrinology and Oncology ’Gateano Salvatore' (IEOS), National Research Council (CNR), Naples, Italy PubMed articlesGoogle scholar articles
  • Mohey Eldin M El Shikh Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK PubMed articlesGoogle scholar articles
  • Frances Humby Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK PubMed articlesGoogle scholar articles
  • Costantino Pitzalis Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Costantino Pitzalis, Centre for Experimental Medicine & Rheumatology, William Harvey Research Institute, Barts and The London School of Medicine & Dentistry, Queen Mary University of London, London EC1M 6BQ, UK; c.pitzalis{at}qmul.ac.uk
View Full Text

Citation

Rivellese F, Mauro D, Nerviani A, et al
Mast cells in early rheumatoid arthritis associate with disease severity and support B cell autoantibody production

Publication history

  • Received March 14, 2018
  • Revised July 26, 2018
  • Accepted July 27, 2018
  • First published August 20, 2018.
Online issue publication 
November 16, 2018

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.